[Congressional Record Volume 172, Number 71 (Wednesday, April 22, 2026)]
[Senate]
[Pages S2034-S2035]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 5404. Mr. BOOKER submitted an amendment intended to be proposed by 
him to the concurrent resolution S. Con. Res. 33, setting forth the 
congressional budget for the United States Government for fiscal year 
2026 and setting forth the appropriate budgetary levels for fiscal 
years 2027 through 2035; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO 
                   SUPPORTING RARE DISEASE PATIENTS.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this

[[Page S2035]]

     resolution, and make adjustments to the pay-as-you-go ledger, 
     for one or more bills, joint resolutions, amendments, 
     amendments between the Houses, motions, or conference reports 
     relating to supporting rare disease patients, which may 
     include investing in rare disease research and maintaining 
     adequate staffing levels at the Department of Health and 
     Human Services and the Food and Drug Administration, by the 
     amounts provided in such legislation for those purposes, 
     provided that such legislation would not increase the deficit 
     over the period of the total of fiscal years 2026 through 
     2035.
                                 ______